GENAZZANI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 21.148
AS - Asia 8.838
EU - Europa 8.672
SA - Sud America 1.246
AF - Africa 167
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 40.098
Nazione #
US - Stati Uniti d'America 20.973
GB - Regno Unito 3.499
CN - Cina 2.913
SG - Singapore 2.889
IT - Italia 1.481
HK - Hong Kong 1.272
BR - Brasile 1.032
SE - Svezia 851
DE - Germania 725
UA - Ucraina 581
TR - Turchia 441
VN - Vietnam 422
RU - Federazione Russa 396
FI - Finlandia 329
KR - Corea 242
BG - Bulgaria 226
IN - India 119
FR - Francia 115
ID - Indonesia 93
AR - Argentina 86
CA - Canada 72
ES - Italia 72
MX - Messico 71
NL - Olanda 71
IE - Irlanda 66
PK - Pakistan 57
JP - Giappone 54
ZA - Sudafrica 53
IQ - Iraq 52
PL - Polonia 51
IR - Iran 43
BD - Bangladesh 40
LT - Lituania 38
EC - Ecuador 36
EG - Egitto 33
MA - Marocco 27
RO - Romania 25
AU - Australia 21
BE - Belgio 20
PH - Filippine 20
AT - Austria 19
PE - Perù 18
IL - Israele 17
MY - Malesia 17
AE - Emirati Arabi Uniti 16
CO - Colombia 16
SA - Arabia Saudita 16
VE - Venezuela 16
UZ - Uzbekistan 15
CL - Cile 14
PT - Portogallo 14
UY - Uruguay 14
CZ - Repubblica Ceca 13
AZ - Azerbaigian 12
KZ - Kazakistan 12
PY - Paraguay 12
HU - Ungheria 11
KG - Kirghizistan 11
GR - Grecia 10
JO - Giordania 10
KE - Kenya 10
CH - Svizzera 9
AL - Albania 8
GH - Ghana 8
TN - Tunisia 8
DZ - Algeria 7
NP - Nepal 6
PA - Panama 6
RS - Serbia 6
CR - Costa Rica 5
EE - Estonia 5
LB - Libano 5
NG - Nigeria 5
TH - Thailandia 5
YE - Yemen 5
HN - Honduras 4
MD - Moldavia 4
NO - Norvegia 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
EU - Europa 3
GE - Georgia 3
KH - Cambogia 3
LK - Sri Lanka 3
LV - Lettonia 3
MK - Macedonia 3
MN - Mongolia 3
MT - Malta 3
NI - Nicaragua 3
OM - Oman 3
SI - Slovenia 3
SN - Senegal 3
TZ - Tanzania 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BZ - Belize 2
DK - Danimarca 2
Totale 40.065
Città #
Southend 2.535
Fairfield 2.494
Santa Clara 2.052
Ashburn 1.663
Singapore 1.631
Woodbridge 1.618
Houston 1.269
Hong Kong 1.260
Jacksonville 1.186
Hefei 1.131
Chandler 1.040
Seattle 913
Wilmington 846
Ann Arbor 772
Cambridge 751
Dearborn 678
London 588
Nyköping 534
Beijing 496
Los Angeles 358
Chicago 345
Modena 332
Princeton 242
San Diego 236
Seoul 231
Sofia 222
Buffalo 204
Eugene 193
Council Bluffs 168
Izmir 168
Ho Chi Minh City 154
The Dalles 141
Salt Lake City 135
Munich 115
Moscow 109
Shanghai 99
Hanoi 98
Helsinki 98
Milan 84
São Paulo 80
Columbus 74
Des Moines 69
Bremen 67
Redwood City 66
Elk Grove Village 65
New York 65
Dublin 64
Dallas 63
Rome 62
Bologna 59
Tampa 57
Jakarta 53
Kent 50
Boardman 48
Norwalk 43
Turku 41
Frankfurt am Main 40
Guangzhou 40
Falls Church 37
Istanbul 37
Rio de Janeiro 35
Lancaster 32
Tokyo 32
Detroit 29
Sterling 28
Phoenix 27
Redondo Beach 27
Philadelphia 26
Warsaw 26
Belo Horizonte 25
Kunming 25
Dongguan 24
Brasília 23
Johannesburg 23
Kilburn 23
Parma 23
Miami 22
Haiphong 20
Verona 20
Dulles 19
Baghdad 18
Brooklyn 18
Chiswick 18
Hounslow 18
San Mateo 18
Jinan 17
Mexico City 17
Mumbai 17
Naples 17
Boston 16
Brussels 16
Cairo 16
Curitiba 16
Lima 16
Montreal 16
Nanjing 16
Orem 16
Florence 15
Indiana 15
Porto Alegre 15
Totale 29.209
Nome #
Increased adrenal steroid secretion in response to CRF in women with hypothalamic amenorrhea 628
Effects of a Combination of Alpha Lipoic Acid and Myo-Inositol on Insulin Dynamics in Overweight/Obese Patients with PCOS. 416
Hypothalamic amenorrhea: from diagnosis to therapeutical approach. 347
Inositol as putative integrative treatment for PCOS 346
Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback 339
Analgesia and endocrine surgical stress: effect of two analgesia protocols on cortisol and prolactin levels during abdominal aortic aneurysm endovascular repair. 330
Validation of italian version of the Women's Health Questionnaire: Assessment of quality of life of women from the general population and those attending menopause centers 310
Might DHEA be Considered a Beneficial Replacement Therapy in the Elderly ? 309
Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. 296
Neuroendocrine changes in luteal function in patients with premenstrual syndrome. 291
One-year therapy with 10 mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu 289
Life events impact in patients with secondary amenorrhoea. 284
Acetyl-L-Carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea 283
Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia 281
Diagnostic and therapeutic approach to hypothalamic amenorrhea 269
Use of metformin in the treatment of polycystic ovary syndrome 267
Spontaneous endogenous pulsatile release of kisspeptin is temporally coupled with luteinizing hormone in healthy women 260
Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. 260
Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients 258
Acute infusion of naloxone, an opioid receptor antagonist, does not modify serum leptin concentrations in amenorrheic and healthy women 255
Estriol administration modulates luteinizing hormone secretion in women with functional hypothalamic amenorrhea 253
Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients 253
Effect of a 2-month treatment with Klamin®, a Klamath algae extract, on the general well-being, antioxidant profile and oxidative status of postmenopausal women 248
Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome 247
Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients 246
Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling 246
Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome 246
Effetto degli estratti di alga Klamath sul benessere e sui fenomeni di stress ossidativo nelle pazienti in menopausa 242
Inositol and human reproduction. From cellular metabolism to clinical use 239
Advances in neurosteroids: Role in clinical practice 235
Dall'uso del solo DHEA alla sua associazione con la terapia ormonale sostitutiva 235
Estimation of instantaneous secretory rates and intrinsic characteristics of luteinizing hormone secretion in women with Kallmann syndrome before and after estriol administration. 234
Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle 234
Allopregnanolone concentrations and premenstrual syndrome 232
Color Doppler analysis in oligo and amenorrheic women with polycystic ovary syndrome 229
Actin Cytoskeleton Remodelling by Sex Steroids in Neurones 227
A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program. 226
A long-term treatment with gonadotropin-releasing hormone agonist plus a low-dose oral contraceptive improves the recovery of the ovulatory function in patients with polycystic ovary syndrome. 225
Modulatory effects of l-carnitine plus l-acetyl-carnitine on neuroendocrine control of hypothalamic functions in functional hypothalamic amenorrhea (FHA) 224
Different concentrations of interleukins in the peritoneal fluid of women with endometriosis: relationships with lymphocyte subsets 223
Short-term estriol administration modulates hypothalamo-pituitary function in patients with functional hypothalamic amenorrhea (FHA) 223
Obesità e benessere: i rischi per la salute della donna obesa 222
La Sindrome Premestruale: clinica, fisiopatologia e indicazioni terapeutiche 222
The relevance of inositols treatment for PCOS before and during ART 218
Effects of hormone replacement therapy on plasma viscosity and Doppler variations in postmenopausal non-smokers and heavy smokers 214
Episodic secretion of activin A in pregnant women 213
Pulsatile secretion of ACTH and cortisol in premenopausal women: effect of obesity and body fat distribution 209
Adrenal function under long-term raloxifene administration 208
EFFECT OF CORTICOTROPIN-RELEASING FACTOR-BINDING PROTEIN ON PROSTAGLANDIN RELEASE FROM CULTURED MATERNAL DECIDUA AND ON CONTRACTILE ACTIVITY OF HUMAN MYOMETRIUM IN-VITRO 207
Changes in Dopaminergic control of circulating melanocyte- stimulating hormone-related peptides at puberty. 207
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS 207
FSH SECRETORY PATTERN AND DEGREE OF CONCORDANCE WITH LH IN AMENORRHEIC, FERTILE, AND POSTMENOPAUSAL WOMEN. 206
Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. 201
Assessment of the QoL in Italian menopausal women: Comparison between HRT users and non-users 201
Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause 201
Naltrexone administration modulates the neuroendocrine control of luteinizing hormone secretion in hypothalamic amenorrhoea. 198
PULSATILE SECRETION OF GONADOTROPINS AND PROLACTIN DURING THE FOLLICULAR AND LUTEAL PHASES OF THE MENSTRUAL-CYCLE - ANALYSIS OF INSTANTANEOUS SECRETION RATE AND SECRETORY CONCOMITANCE 197
Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance 197
Effects of red clover extracts on breast cancer cell migration and invasion 196
Effects of estetrol on migration and invasion inT47-D breast cancer cells through the actin cytoskeleton 196
Color Doppler analysis in lean and obese women with polycystic ovary syndrome. 196
The role of color doppler imaging in the diagnosis of polycystic ovary syndrome 196
Color Doppler hysterosalpingography in the diagnosis of tubal patency. 195
Progestinici e fibromatosi uterina 195
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders 194
Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia 194
Dydrogesterone exerts endothelial anti-inflammatory actions decreasing expression of leukocyte adhesion molecules 194
Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea 193
Effects of Klamath Algae extract on psychological disorders and depression in menopausal women: a pilot study 192
. Opioid control of gonadotrophin secretion in humans. 191
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1) 190
Effects of cyproheptadine clorhydrate, a serotonin receptor antagonist, on endocrine parameters in weight-loss related amenorrhea 190
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat. 190
Bollettino di Endocrinologia Ginecologica 189
Acetyl-L-Carnitine effect on pituitary and plasma *-endorphin responsiveness to different chronic intermittent stressors. 189
Which form of HRT should we choose? 188
Hypothalamic amenorrhea in a Camurati-Engelmann disease-a case report 187
The duration of prolactin secretory bursts from the pituitary is independent from both prolactin and gonadal steroid plasma levels in women and in men 187
Melatonin treatment delays reproductive aging of female rat via the opiatergic system. 186
Neuroendocrine effects of different estradiol-progestin regimens in postmenopausal women 186
FREQUENCY OF PROLACTIN PULSATILE RELEASE IN NORMAL MEN AND IN AGONADAL PATIENTS IS NEITHER COUPLED TO LH-RELEASE NOR INFLUENCED BY ANDROGEN MODULATION 186
Female precocious puberty, obesity and polycystic-like ovaries 185
Ultrasonographic and color Doppler analysis in the treatment of polycystic ovary syndrome 185
Neuromodulatory role of opioidergic system on hypothalamus-pituitary-gonadal axis during puberty 184
Effect of short term sibutramine on gonadotropin spontaneous pulsatile release in normogonadotropinemic amenorrheic subjects 183
Surgical technique of endometrioma excision impacts on the ovarian reserve. Single-port access laparoscopy versus multiport access laparoscopy: a case control study 182
DHEA as a putative replacement therapy in the elderly 182
Estrogen replacement therapy modulates spontaneous GH secretion but does not affect GH-RH-induced GH response and low T3 syndrome in women with hypothalamic amenorrhea associated to weight-loss 181
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 180
Endocrinologia Ginecologica 179
Corticotropin-releasing factor-binding protein: Origins and possible functions 178
Aspetti endocrini, diagnostici e terapeutici delle menimetrorragie in età perimenopausale. 177
Modulatory effects of a synthetic steroid (tibolone) and estradiol on spontaneous and GH-RH-induced GH secretion in postmenopausal women 175
Hypothalamic amenorrhea: Neuroendocrine mechanisms / stress-induced anomalies 173
Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea 173
Spontaneous episodic release of adenohypophyseal hormones in hypothalamic amenorrhea. 171
Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome 171
Maternal plasma and placental immunoreactive corticotrophin-releasing factor concentrations in infection-associated term and pre-term delivery 171
Sterss nel paziente odontoiatrico 170
Estetrol modulates endothelial nitric oxide synthesis in human endothelial cells 170
Totale 22.583
Categoria #
all - tutte 175.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 175.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.576 0 0 0 0 0 297 392 723 131 572 218 243
2021/20223.487 66 595 353 284 66 116 279 200 355 217 546 410
2022/20233.192 360 282 178 272 396 518 57 285 429 45 154 216
2023/20242.352 93 145 144 152 558 205 248 326 36 74 147 224
2024/20258.093 334 106 80 620 1.540 1.033 358 490 1.091 744 782 915
2025/20267.569 1.059 725 1.632 1.677 2.214 262 0 0 0 0 0 0
Totale 40.433